Compare Ingersoll Rand (IR) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ingersoll Rand vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Ingersoll Rand trades at $78.16 (market cap $30.26B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.32 (market cap $2.27B). The key difference: Ingersoll Rand is far larger — about 13.3× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Ingersoll Rand pays a 0.1% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| IR | SLS | |
|---|---|---|
Market Cap | $30.26B | $2.27B |
Volume | 4,017,622 | 4,179,659 |
Sector | Industrials | Health |
52-Week High | $98.76 | $15.46 |
52-Week Low | $68.54 | $1.39 |
Typical Hold Time | 7 Days | — |
Enterprise Value | $33.92B | $2.14B |
Dividend Yield | 0.1% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ingersoll Rand
Ingersoll Rand develops industrial technologies for creating and managing flow, pressure, and motion. Its portfolio includes compressors, pumps, vacuum systems, and other equipment used across industrial markets.
Read more on IR →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
